Related Articles
Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas
Radiation therapy with uneven fractionation for malignant gliomas.
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6
A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma
Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells